alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,701–22,725 of 27,380 studies, newest first · page 909 of 1096.

March 2007 15

  1. 2007-03-01

    Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

    ✓ Peer-reviewed Brain tissue and pathology Archives of neurology

    Key finding: Patient A 76-year-old man with a clinical diagnosis of dementia with Lewy bodies underwent fluorodeoxyglucose (18)F and PiB positron emission tomographic brain scans. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2007-03-01

    Longitudinal change in cognitive performance among individuals with mild cognitive impairment

    ✓ Peer-reviewed Cognitive tests and assessment Neuropsychology

    Key finding: At follow-up, the participants were divided into 4 groups: (a) controls: participants who were normal at both baseline and follow-up (n = 33), (b) stables: participants with MCI whose Clinical Dementia Rating-Sum of Boxes (CDR-SB) score did not differ between the first and last evaluations (n = 22), (c) decliners: participants with MCI whose CDR-SB score declined between the first and last evaluations (n = 95), and (d) converters: participants who received a clinical diagnosis of Alzheimer's disease during the follow-up period (n = 47). +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2007-03-01

    FMRP mediates mGluR5-dependent translation of amyloid precursor protein

    ✓ Peer-reviewed Risk genes beyond APOE PLoS biology

    Key finding: Fragile X mental retardation protein (FMRP) is a cytoplasmic mRNA binding protein whose expression is lost in fragile X syndrome. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2007-03-01

    Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of Alzheimer's disease : JAD

    Key finding: Neurobiological studies of similarly aged DS autopsy cases provide further evidence of activation of plasticity mechanisms. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2007-03-01

    A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia

    ✓ Peer-reviewed Digital health tools Journal of the International Neuropsychological Society : JINS

    Key finding: In Alzheimer's disease (AD), it is usually associated with global cognitive deficits. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2007-03-01

    Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease

    ✓ Peer-reviewed How common it is Archives of neurology

    Key finding: The plasma Abeta42/Abeta40 ratio may be a useful premorbid biomarker for identifying cognitively normal elderly white subjects who are at increased risk for developing MCI or AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2007-03-01

    Decisions to forgo hospitalization in advanced dementia: a nationwide study

    ✓ Peer-reviewed Disparities Journal of the American Geriatrics Society

    Key finding: Directives to forgo hospitalization for U.S. NH residents with advanced dementia are uncommon and are associated with the organizational features of the facilities caring for them and the intensity of end-of-life care practiced in the region, as well as individual resident characteristics. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2007-03-01

    Correlates of physical health of informal caregivers: a meta-analysis

    ✓ Peer-reviewed Caregiving The journals of gerontology. Series B, Psychological sciences and social sciences

    Key finding: This meta-analysis integrates results from 176 studies on correlates of caregiver physical health.

    Full summary, score breakdown and related studies → Original source

  9. 2007-03-01

    Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Systemic inflammation is associated with ischemia and Alzheimer disease (AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2007-03-01

    Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Hippocampal and entorhinal cortex volumes were each largest in controls, intermediate in MCI nonconverters, and smallest in MCI converters to AD (37 of 139 patients converted to AD).

    Full summary, score breakdown and related studies → Original source

  11. 2007-03-01

    DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: We concluded that the differing temporal sequence of symptoms and clinical features of PDD and DLB justify distinguishing these disorders.

    Full summary, score breakdown and related studies → Original source

  12. 2007-03-01

    IANA task force on nutrition and cognitive decline with aging

    ✓ Peer-reviewed Prevention and risk The journal of nutrition, health & aging

    Key finding: Cognitive impairment can be influenced by a number of factors. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2007-03-01

    [Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]

    ✓ Peer-reviewed Treatments L'Encephale

    Key finding: Compared to entry results, episodic memory decreased in group D + P but improved in group S + D. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2007-03-01

    AMPA potentiator treatment of cognitive deficits in Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Patients treated with LY451395 did not show a statistically significant separation from patients taking placebo on the Alzheimer's Disease Assessment Scale-Cognitive Subscale, the primary outcome measure. +2 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2007-03-01

    Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: The relationship between serum total cholesterol (TC) and dementia seems to be bidirectional. +4 more findings

    Full summary, score breakdown and related studies → Original source

February 2007 10

  1. 2007-02-28

    Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy

    ✓ Peer-reviewed Risk factors Journal of the neurological sciences

    Key finding: Despite extensive evaluations, a procoagulant state has never been demonstrated.

    Full summary, score breakdown and related studies → Original source

  2. 2007-02-28

    Calcium and neurodegeneration

    ✓ Peer-reviewed Genetics Aging cell

    Key finding: During aging, and particularly in neurodegenerative disorders, cellular Ca2+-regulating systems are compromised resulting in synaptic dysfunction, impaired plasticity and neuronal degeneration. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2007-02-28

    Spatial navigation deficit in amnestic mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Proceedings of the National Academy of Sciences of the United States of America

    Key finding: The amnestic MCI single-domain group was impaired significantly in subtests focused on allocentric orientation and at the beginning of the real space egocentric subtest, suggesting impaired memory for allocentric and real space configurations. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2007-02-27

    AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides

    ✓ Peer-reviewed How common it is BMC bioinformatics

    Key finding: By identifying aggregation-prone segments in proteins, AGGRESCAN http://bioinf.uab.es/aggrescan/ shall facilitate (i) the identification of possible therapeutic targets for anti-depositional strategies in conformational diseases and (ii) the anticipation of aggregation phenomena during storage or recombinant production of bioactive polypeptides or polypeptide sets.

    Full summary, score breakdown and related studies → Original source

  5. 2007-02-27

    GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

    ✓ Peer-reviewed Brain tissue and pathology The Journal of pharmacology and experimental therapeutics

    Key finding: GSK189254 is >10,000-fold selective for human H(3) receptors versus other targets tested, and it exhibited potent functional antagonism (pA(2) = 9.06 versus agonist-induced changes in cAMP) and inverse agonism [pIC(50) = 8.20 versus basal guanosine 5'-O-(3-[(35)S]thio)triphosphate binding] at the human recombinant H(3) receptor. +3 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2007-02-22

    Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants

    ✓ Peer-reviewed Genetics Human molecular genetics

    Key finding: A tiered strategy was used to follow-up significant variants from the discovery sample in four independent sample sets. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2007-02-21

    Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications

    ✓ Peer-reviewed Disease mechanisms Steroids

    Key finding: Signaling mechanisms underlying estrogen-induced neuroprotection and synaptic plasticity are reviewed, including the important concepts of genomic versus nongenomic mechanisms, types of estrogen receptor involved and their subcellular targeting, and implicated downstream signaling pathways and mediators.

    Full summary, score breakdown and related studies → Original source

  8. 2007-02-21

    CSF neurofilament proteins in the differential diagnosis of dementia

    ✓ Peer-reviewed Biomarkers Journal of neurology, neurosurgery, and psychiatry

    Key finding: In the diagnostic workup of relatively young dementia patients, CSF NFL levels may play a role in the discrimination between FTLD and EAD, especially in combination with Abeta42 and p-tau181 analysis. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2007-02-21

    Aging effects on cerebral blood and cerebrospinal fluid flows

    ✓ Peer-reviewed Vascular contributions Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    Key finding: Total cerebral blood flow was (P<0.01) decreased significantly in the elderly group when compared with the young subjects with a linear correlation with age observed only in the elderly group (R(2)=0.7; P=0.05). +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2007-02-21

    Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils

    ✓ Peer-reviewed Inflammation and the immune system Molecular biology of the cell

    Key finding: Primary mouse microglia can internalize fAbeta, but they do not degrade it efficiently. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →